Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Current Fungal Infection Reports
Erschienen in: Current Fungal Infection Reports 4/2011

01.12.2011 | Epidemiologic Aspects of Fungal Infections (Tom M. Chiller, Section Editor)

Penicillium marneffei Infection: Knowledge, Gaps, and Future Directions

verfasst von: Alanna Stone, Benjamin J. Park

Erschienen in: Current Fungal Infection Reports | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Penicilliosis is a disease caused by Penicillium marneffei, a fungus endemic to Southeast Asia. Prior to the HIV/AIDS epidemic, infection was exceedingly rare, but penicilliosis is currently one of the most common opportunistic infections in persons with HIV/AIDS in some Asian countries. This paper describes the clinical manifestations, diagnosis, and epidemiology of this emerging opportunistic infection and will focus on some gaps in our knowledge and directions for future research.
Literatur
1.
Supparatpinyo K et al. Disseminated Penicillium marneffei infection in Southeast Asia. Lancet. 1994;344(8915):110–3.PubMedCrossRef
2.
Capponi M, Sureau P, Segretain G. Penicillose de Rhizomys sinensis. Bull Soc Pathol Exot. 1956;49:418–21.
3.
Segretain G. Penicillium marneffei n.sp., agent of a mycosis of the reticuloendothelial system. Mycopathologia. 1959;11:327–53.PubMed
4.
DiSalvo AF, Fickling AM, Ajello L. Infection caused by Penicillium marneffei: description of first natural infection in man. Am J Clin Pathol. 1973;60(2):259–63.PubMed
5.
Jayanetra P et al. Penicilliosis marneffei in Thailand: report of five human cases. Am J Trop Med Hyg. 1984;33(4):637–44.PubMed
6.
Piehl MR, Kaplan RL, Haber MH. Disseminated penicilliosis in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1988;112(12):1262–4.PubMed
7.
Vanittanakom N et al. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev. 2006;19(1):95–110.PubMedCrossRef
8.
Fisher MC et al. Multilocus microsatellite typing system for Penicillium marneffei reveals spatially structured populations. J Clin Microbiol. 2004;42(11):5065–9.PubMedCrossRef
9.
Duong TA. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin Infect Dis. 1996;23(1):125–30.PubMedCrossRef
10.
Chang KC et al. Penicillium marneffei infection and solitary pulmonary nodule. Hong Kong Med J. 1998;4(1):59–62.PubMed
11.
Deesomchok A, Tanprawate S. A 12-case series of Penicillium marneffei pneumonia. J Med Assoc Thai. 2006;89(4):441–7.PubMed
12.
Zhiyong Z, Mei K, Yanbin L. Disseminated Penicillium marneffei infection with fungemia and endobronchial disease in an AIDS patient in China. Med Princ Pract. 2006;15(3):235–7.PubMedCrossRef
13.
Cheng NC et al. Unusual pulmonary manifestations of disseminated Penicillium marneffei infection in three AIDS patients. Med Mycol. 1998;36(6):429–32.PubMed
14.
Pautler KB, Padhye AA, Ajello L. Imported Penicilliosis marneffei in the United States: report of a second human infection. Sabouraudia. 1984;22(5):433–8.PubMedCrossRef
15.
Supparatpinyo K et al. Penicillium marneffei infection in patients infected with human immunodeficiency virus. Clin Infect Dis. 1992;14(4):871–4.PubMedCrossRef
16.
Mootsikapun P, Srikulbutr S. Histoplasmosis and penicilliosis: comparison of clinical features, laboratory findings and outcome. Int J Infect Dis. 2006;10(1):66–71.PubMedCrossRef
17.
Deng ZL, Connor DH. Progressive disseminated penicilliosis caused by Penicillium marneffei. Report of eight cases and differentiation of the causative organism from Histoplasma capsulatum. Am J Clin Pathol. 1985;84(3):323–7.PubMed
18.
Cao L et al. Detection of specific antibodies to an antigenic mannoprotein for diagnosis of Penicillium marneffei penicilliosis. J Clin Microbiol. 1998;36(10):3028–31.PubMed
19.
Kaufman L et al. Diagnostic antigenemia tests for Penicilliosis marneffei. J Clin Microbiol. 1996;34(10):2503–5.PubMed
20.
Desakorn V et al. Development and evaluation of rapid urinary antigen detection tests for diagnosis of Penicilliosis marneffei. J Clin Microbiol. 2002;40(9):3179–83.PubMedCrossRef
21.
Huang YT et al. Detection of circulating galactomannan in serum samples for diagnosis of Penicillium marneffei infection and cryptococcosis among patients infected with human immunodeficiency virus. J Clin Microbiol. 2007;45(9):2858–62.PubMedCrossRef
22.
Notomi T et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000;28(12):E63.PubMedCrossRef
23.
• Sun J, et al. Development and evaluation of loop-mediated isothermal amplification (LAMP) for the rapid diagnosis of Penicillium marneffei in archived tissue samples. FEMS Immunol Med Microbiol. 2010;58(3):381–8. This paper describes a process that may be used in the diagnosis of P. marneffei infections. This is an important paper because currently, limited diagnostics are available in the settings where this disease is commonly seen. Further refinement of this assay may be a promising step toward improving diagnosis for penicilliosis. PubMed
24.
Chariyalertsak S et al. Seasonal variation of disseminated Penicillium marneffei infections in northern Thailand: a clue to the reservoir? J Infect Dis. 1996;173(6):1490–3.PubMedCrossRef
25.
Chariyalertsak S et al. Case-control study of risk factors for Penicillium marneffei infection in human immunodeficiency virus-infected patients in northern Thailand. Clin Infect Dis. 1997;24(6):1080–6.PubMedCrossRef
26.
Sirisanthana V, Sirisanthana T. Disseminated Penicillium marneffei infection in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 1995;14(11):935–40.PubMedCrossRef
27.
Chang CC et al. Disseminated Penicillium marneffei infection in a patient with acquired immunodeficiency syndrome. J Formos Med Assoc. 1995;94(9):572–5.PubMed
28.
Tsui WM, Ma KF, Tsang DN. Disseminated Penicillium marneffei infection in HIV-infected subject. Histopathology. 1992;20(4):287–93.PubMedCrossRef
29.
Hien TV et al. First cases of disseminated Penicilliosis marneffei infection among patients with acquired immunodeficiency syndrome in Vietnam. Clin Infect Dis. 2001;32(4):e78–80.PubMedCrossRef
30.
Deng Z, Liu X. Disseminated Penicilliosis marneffei in a patient with acquired immunodeficiency syndrome: a first case report from China. Chin Med J (Engl). 2000;113(11):1049–50.
31.
Wong KH et al. Redefining AIDS: case exemplified by Penicillium marneffei infection in HIV-infected people in Hong Kong. Int J STD AIDS. 1998;9(9):555–6.PubMedCrossRef
32.
Wu TC et al. Clinical presentations and outcomes of Penicillium marneffei infections: a series from 1994 to 2004. Hong Kong Med J. 2008;14(2):103–9.PubMed
33.
Hung CC et al. Invasive infection caused by Penicillium marneffei: an emerging pathogen in Taiwan. Clin Infect Dis. 1998;26(1):202–3.PubMedCrossRef
34.
Ranjana KH et al. Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur state, India. J Infect. 2002;45(4):268–71.PubMedCrossRef
35.
Devi KR et al. Penicillium marneffei—an indicator disease of AIDS: a case report. Indian J Pathol Microbiol. 2007;50(3):674–6.PubMed
36.
George IA et al. Acute abdomen: an unusual presentation of disseminated Penicillium marneffei infection. Indian J Med Microbiol. 2008;26(2):180–2.PubMedCrossRef
37.
Maniar JK et al. Penicillium marneffei infection: an AIDS-defining illness. Indian J Dermatol Venereol Leprol. 2005;71(3):202–4.PubMedCrossRef
38.
Michael JS et al. Varied clinical manifestations of Penicillium marneffei in patients with human immunodeficiency virus: a report from south India. Mycoses. 2005;48(2):120–1.PubMedCrossRef
39.
Saikia L et al. Penicillium marneffei infection in HIV infected patients in Nagaland & immune reconstitution after treatment. Indian J Med Res. 2009;129(3):333–4.PubMed
40.
Sharma A et al. Penicillium marneffei infection in a HIV infected child. Indian J Med Res. 2007;126(6):580–2.PubMed
41.
Singh PN et al. Indigenous disseminated Penicillium marneffei infection in the state of Manipur, India: report of four autochthonous cases. J Clin Microbiol. 1999;37(8):2699–702.PubMed
42.
Rokiah I, Ng KP, Soo-Hoo TS. Penicillium marneffei infection in an AIDS patient—a first case report from Malaysia. Med J Malaysia. 1995;50(1):101–4.PubMed
43.
Hilmarsdottir I et al. A French case of laboratory-acquired disseminated Penicillium marneffei infection in a patient with AIDS. Clin Infect Dis. 1994;19(2):357–8.PubMedCrossRef
44.
Hilmarsdottir I et al. Disseminated Penicillium marneffei infection associated with human immunodeficiency virus: a report of two cases and a review of 35 published cases. J Acquir Immune Defic Syndr. 1993;6(5):466–71.PubMed
45.
Valeyrie L et al. Prolonged fever revealing disseminated infection due to Penicillium marneffei in a French HIV-seropositive patient. AIDS. 1999;13(6):731–2.PubMedCrossRef
46.
Nord J, Karter D, LaBombardi V. An AIDS patient with fever and pancytopenia. Int J Infect Dis. 1998;2(3):173–5.PubMedCrossRef
47.
Sobottka I et al. Systemic Penicillium marneffei infection in a German AIDS patient. Eur J Clin Microbiol Infect Dis. 1996;15(3):256–9.PubMedCrossRef
48.
Rimek D et al. Disseminated Penicillium marneffei infection in an HIV-positive female from Thailand in Germany. Mycoses. 1999;42 Suppl 2:25–8.PubMed
49.
Lo Y et al. Disseminated Penicillium marneffei infection in an African AIDS patient. Trans R Soc Trop Med Hyg. 2000;94(2):187.PubMedCrossRef
50.
Viviani MA et al. Treatment and serological studies of an Italian case of Penicilliosis marneffei contracted in Thailand by a drug addict infected with the human immunodeficiency virus. Eur J Epidemiol. 1993;9(1):79–85.PubMedCrossRef
51.
Antinori S et al. Disseminated Penicillium marneffei infection in an HIV-positive Italian patient and a review of cases reported outside endemic regions. J Travel Med. 2006;13(3):181–8.PubMedCrossRef
52.
Jones PD, See J. Penicillium marneffei infection in patients infected with human immunodeficiency virus: late presentation in an area of nonendemicity. Clin Infect Dis. 1992;15(4):744.PubMedCrossRef
53.
Heath TC et al. Disseminated Penicillium marneffei: presenting illness of advanced HIV infection; a clinicopathological review, illustrated by a case report. Pathology. 1995;27(1):101–5.PubMedCrossRef
54.
Depraetere K et al. Two imported cases of Penicillium marneffei infection in Belgium. Acta Clin Belg. 1998;53(4):255–8.PubMed
55.
Mohri S et al. A case of Penicillium marneffei infection in an AIDS patient: the first case in Japan. Nippon Ishinkin Gakkai Zasshi. 2000;41(1):23–6.CrossRef
56.
Tsunemi Y, Takahashi T, Tamaki T. Penicillium marneffei infection diagnosed by polymerase chain reaction from the skin specimen. J Am Acad Dermatol. 2003;49(2):344–6.PubMedCrossRef
57.
Julander I, Petrini B. Penicillium marneffei infection in a Swedish HIV-infected immunodeficient narcotic addict. Scand J Infect Dis. 1997;29(3):320–2.PubMedCrossRef
58.
Remadi S et al. Penicillium marneffei infection in patients infected with the human immunodeficiency virus. A report of two cases. Acta Cytol. 1995;39(4):798–802.PubMed
59.
Hulshof CM et al. Penicillium marneffei infection in an AIDS patient. Eur J Clin Microbiol Infect Dis. 1990;9(5):370.PubMedCrossRef
60.
Kok I et al. Disseminated Penicillium marneffei infection as an imported disease in HIV-1 infected patients. Description of two cases and a review of the literature. Neth J Med. 1994;44(1):18–22.PubMed
61.
Mens H, Hojlyng N, Arendrup MC. Disseminated Penicillium marneffei sepsis in a HIV-positive Thai woman in Denmark. Scand J Infect Dis. 2004;36(6–7):507–9.PubMedCrossRef
62.
Peto TE et al. Systemic mycosis due to Penicillium marneffei in a patient with antibody to human immunodeficiency virus. J Infect. 1988;16(3):285–90.PubMedCrossRef
63.
McShane H, Tang CM, Conlon CP. Disseminated Penicillium marneffei infection presenting as a right upper lobe mass in an HIV positive patient. Thorax. 1998;53(10):905–6.PubMedCrossRef
64.
Vilar FJ et al. Disseminated Penicillium marneffei in a patient infected with human immunodeficiency virus. Int J STD AIDS. 2000;11(2):126–8.PubMedCrossRef
65.
Skoulidis F, Morgan MS, MacLeod KM. Penicillium marneffei: a pathogen on our doorstep? J R Soc Med. 2004;97(8):394–6.PubMedCrossRef
66.
Filiotou A et al. First case of Penicillium marneffei fungemia in Greece and strain susceptibility to five licensed systemic antifungal agents and posaconazole. Am J Med Sci. 2006;332(1):43–5.PubMedCrossRef
67.
Kurup A et al. Disseminated Penicillium marneffei infection: a report of five cases in Singapore. Ann Acad Med Singapore. 1999;28(4):605–9.PubMed
68.
Ajello L et al. Occurrence of Penicillium marneffei infections among wild bamboo rats in Thailand. Mycopathologia. 1995;131(1):1–8.PubMedCrossRef
69.
Deng ZL, Yun M, Ajello L. Human Penicilliosis marneffei and its relation to the bamboo rat (Rhizomys pruinosus). J Med Vet Mycol. 1986;24(5):383–9.PubMedCrossRef
70.
Chariyalertsak S et al. Rhizomys sumatrensis and Cannomys badius, new natural animal hosts of Penicillium marneffei. J Med Vet Mycol. 1996;34(2):105–10.PubMedCrossRef
71.
Gugnani H et al. Role of Cannomys badius as a natural animal host of Penicillium marneffei in India. J Clin Microbiol. 2004;42(11):5070–5.PubMedCrossRef
72.
Gugnani HC et al. Occurrence of pathogenic fungi in soil of burrows of rats and of other sites in bamboo plantations in India and Nepal. Mycoses. 2007;50(6):507–11.PubMedCrossRef
73.
Pryce-Miller E et al. Environmental soil detection of Penicllium marneffei and growth in soil microcosms in competition with Talaromyces stipitatus. Fungal Ecol. 2008;1:49–56.CrossRef
74.
Vanittanakom N et al. Efficiency of the flotation method in the isolation of Penicillium marneffei from seeded soil. J Med Vet Mycol. 1995;33(4):271–3.PubMedCrossRef
75.
Lin WC et al. Systemic Penicillium marneffei infection in a child with common variable immunodeficiency. J Formos Med Assoc. 1998;97(11):780–3.PubMed
76.
Lin JN et al. Renal transplant recipient infected with Penicillium marneffei. Lancet Infect Dis. 2010;10(2):138.PubMedCrossRef
77.
Chariyalertsak S et al. A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand. Clin Infect Dis. 2002;34(2):277–84.PubMedCrossRef
78.
Supparatpinyo K et al. An efficacy study of itraconazole in the treatment of Penicillium marneffei infection. J Med Assoc Thai. 1992;75(12):688–91.PubMed
79.
Supparatpinyo K et al. A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus. New Engl J Med. 1998;339(24):1739–43.PubMedCrossRef
80.
Hung CC et al. Discontinuation of secondary prophylaxis for Penicilliosis marneffei in AIDS patients responding to highly active antiretroviral therapy. AIDS. 2002;16(4):672–3.PubMedCrossRef
81.
Chaiwarith R et al. Discontinuation of secondary prophylaxis against Penicilliosis marneffei in AIDS patients after HAART. AIDS. 2007;21(3):365–7.PubMedCrossRef
Metadaten
Titel
Penicillium marneffei Infection: Knowledge, Gaps, and Future Directions
verfasst von
Alanna Stone
Benjamin J. Park
Publikationsdatum
01.12.2011
Verlag
Current Science Inc.
Erschienen in
Current Fungal Infection Reports / Ausgabe 4/2011
Print ISSN: 1936-3761
Elektronische ISSN: 1936-377X
DOI
https://doi.org/10.1007/s12281-011-0067-5

Weitere Artikel der Ausgabe 4/2011

Current Fungal Infection Reports 4/2011 Zur Ausgabe

Epidemiologic Aspects of Fungal Infections (Tom M. Chiller, Section Editor)

Preventing Death from HIV-Associated Cryptococcal Meningitis: The Way Forward

Epidemiologic Aspects of Fungal Infections (Tom M. Chiller, Section Editor)

Histoplasmosis: Epidemiology in Latin America

Epidemiologic Aspects of Fungal Infections (Tom M. Chiller, Section Editor)

Strategies to Combat Coccidioidomycosis: Are We Making Any Progress?

Genomics and Pathogenesis (Shmuel Shoham, Section Editor)

Cryptococcus-Related Immune Reconstitution Inflammatory Syndrome (IRIS): Pathogenesis and its Clinical Implications

UPDATE

Cutaneous Mucormycosis in Tornado Survivors

Epidemiologic Aspects of Fungal Infections (Tom M. Chiller, Section Editor)

Neglected Fungal Diseases in Sub-Saharan Africa: A Call to Action

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise